神田 慎太郎 (カンダ シンタロウ)
学術研究院（医学系（附属病院））
医学部附属病院 信州がんセンター
准教授
研究者情報
研究活動情報
論文
- Treatment Outcomes in Patients with Atypical EGFR-positive Non-small Cell Lung Cancer in Nagano Prefecture, Japan.
Agatsuma T, Kanda S, Yamamoto R, Ono Y, Nishie K, Tanaka H, Matsuo A, Shibutani M, Koizumi T
信州医学雑誌, 70(6), 397-405, 2022年12月
- Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy
Araki T, Tateishi K, Komatsu M, Sonehara K, Wasamoto S, Koyama S, Yoshiike F, Hama M, Nishie K, Kondo D, Agatsuma T, Kato A, Takata M, Kanda S, Hanaoka M, Koizumi T
Thorac Cancer, 13(14), 2031-2040, 2022年 - Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy
Araki T, Tateishi K, Komatsu M, Sonehara K, Kanda S, Hanaoka M, Koizumi T
Thorac Cancer, 13(7), 1006-1013, 2022年 - Factors Affecting Nivolumab Therapy Outcome in Patients with Head and Neck Cancer: A Single-Center Analysis
Iwasa Y, Yokota Y, Kitoh R, Mori K, Tsukada K, Sekiguchi N, Fukushima T, Kobayashi T, Kanda S, Takumi Y, Koizumi T
ONCOLOGY, 100(4), 203-211, 2022年 - Syndrome of Inappropriate Antidiuretic Hormone Secretion as the Initial Presentation in a Patient with Stage I Small-cell Lung Cancer
Koizumi T, Kobayashi T, Kanda S, Fukushima T, Muranaka F, Miura K, Asaka S
Intern Med, 61(5), 709-713, 2022年 - Epidemiology of neuroendocrine neoplasmas in Japan: based on analysis of hospital-based cancer registry data, 2009 – 2015
Koizumi T, Otsuki K, Tanaka Y, Kanda S
BMC Endocr Disord, 22(1), 105, 2022年 - Epidemiological analysis of lung and mediastinal neuroendocrine neoplasms in Japan based on the national database
Matsuoka S, Koizumi T, Otsuki K, Tanaka Y, Kanda S, Ide S, Mishima S, Takeda T, Miura K, Eguchi T, Hamanaka K, Shimizu K
Cancer Epidemiol, 77, 102116, 2022年 - Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant
Hibino H, Sakiyama N, Makino Y, Makihara-Ando R, Horinouchi H, Fujiwara Y, Kanda S, Goto Y, Yoshida T, Okuma Y, Shinno Y, Murakami S, Hashimoto H, Akiyoshi T, Imaoka A, Ohe Y, Yamaguchi M, Ohtani H
Eur J Clin Pharmacol, 78(4), 613-621, 2022年 - Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients
Inaba Higashiyama R, Horinouchi H, Kuchiba A, Matsumoto Y, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Ohe Y
J Cancer Res Clin Oncol, 149(7), 3185-3191, 2022年 - Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience
Okumura T, Noguchi T, Sekiguchi N, Kobayashi T, Kanda S, Ida K, Minagawa T, Tokumaru S, Umemura T, Koizumi T
Chemotherapy, 68(2), 87-94, 2022年 - Clinical utility of the C-reactive protein:albumin ratio in non-small cell lung cancer patients treated with nivolumab
Araki T, Tateishi K, Sonehara K, Hirota S, Komatsu M, Yamamoto M, Kanda S, Kuraishi H, Hanaoka M, Koizumi T
Thorac Cancer, 12(5), 603-612, 2021年 - A Case of Sinonasal Undifferentiated Carcinoma Sucessfully Responding to Chemoradiotherapy
Matsushita Hirohide, Ozawa Takesumi, Sekiguchi Nodoka, Fukushima Toshirou, Kobayashi Takashi, Kanda Shintaro, Koizumi Tomonobu
Shinshu Medical Journal, 69(3), 121-126, 2021年 - 化学療法中にGrowing Teratoma Syndromeを呈した縦隔胚細胞性腫瘍の1例
加藤斐菜子、福嶋敏郎、小林孝至、関口和、神田慎太郎、小泉知展
癌と化学療法, 47, 1497-1500, 2020年 - Difference in central nerve system metastasis during gefitinib or erlotinib therapy in patients with EGFR-mutated non-small cell lung cancer: a retrospective study
Yoshida K, Kanda S, Shiraishi H, Goto K, Itahashi K, Goto Y, Horinouchi H, Fujiwara Y, Nokihara H, Yamamoto N, Ohe Y
J Thorac Dis, 11(4), 1347-1354, 2019年 - Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer
Udagawa H, Akamatsu H, Tanaka K, Takeda M, Kanda S, Kirita K, Teraoka S, Nakagawa K, Fujiwara Y, Yasuda I, Okubo S, Shintani M, Kosloski MP, Scripture C, Tamura T, Okamoto I
Lung Cance, 135, 145-150, 2019年 - Efficacy of subsequent docetaxel +/- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer
Tamura N, Horinouchi H, Sekine K, Matsumoto Y, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Ohe Y
Thorac Cancer, 10(5), 1141-1148, 2019年 - Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute
Sonehara K, Tateishi K, Komatsu M, Yamamoto H, Hanaoka M, Kanda S, Koizumi T
Chemotherapy, 64(3)(129-137), 2019年 - Mixed response to osimertinib and the beneficial effects of additional local therapy
Shinno Y, Goto Y, Sato J, Morita R, Matsumoto Y, Murakami S, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Ohe Y
Thorac Cancer, 10(4)(738-743), 2019年 - Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer
Shibaki R, Murakami S, Shinno Y, Matsumoto Y, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Motoi N, Yamamoto N, Ohe Y
Thorac Cancer, 10(4), 815-822, 2019年 - Tumor expression and usefulness as a biomarker of programmed death ligand 1 in advanced non-small cell lung cancer patients with preexisting interstitial lung disease
Shibaki R, Murakami S, Matsumoto Y, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Motoi N, Kusumoto M, Yamamoto N, Ohe Y
Med Oncol, 36(6), 49, 2019年 - Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer
Nokihara H, Nishio M, Yamamoto N, Fujiwara Y, Horinouchi H, Kanda S, Horiike A, Ohyanagi F, Yanagitani N, Nguyen L, Yaron Y, Borgman A, Tamura T
Clin Lung Cancer, 20(3), e317-e328, 2019年 - A Minimum Of 100 Tumor Cells in a Single Biopsy Sample Is Required to Assess Programmed Cell Death Ligand 1 Expression in Predicting Patient Response to Nivolumab Treatment in Nonsquamous Non-Small Ce
Naito T, Udagawa H, Sato J, Horinouchi H, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Zenke Y, Kirita K, Matsumoto S, Yoh K, Niho S, Motoi N, Ohe Y, Ishii G, Goto K
J Thorac Oncol, 14(10), 1818-1827, 2019年 - Efficacy and safety of crizotinib in patients with ROS1 rearranged non-small cell lung cancer: a retrospective analysis
Masuda K, Fujiwara Y, Shinno Y, Mizuno T, Sato J, Morita R, Matsumoto Y, Murakami S, Goto Y, Kanda S, Horinouchi H, Yamamoto N, Ohe Y
J Thorac Dis, 11(7), 2965-2972, 2019年 - Individual optimal dose of amrubicin to prevent severe neutropenia in Japanese patients with lung cancer
Makino Y, Makihara-Ando R, Ogawa T, Sato H, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Ohe Y, Yamamoto N
Cancer Sci, 110(11), 3573-3583, 2019年 - Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption
Kikuchi K, Nozawa K, Yamazaki N, Nakai Y, Higashiyama A, Asano M, Fujiwara Y, Kanda S, Ohe Y, Takashima A, Boku N, Inoue A, Takahashi M, Mori T, Taguchi O, Inoue Y, Mizutani H
J Dermatol, 46(1), 18-25, 2019年 - Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer
Nokihara H, Nishio M, Yamamoto N, Fujiwara Y, Horinouchi H, Kanda S, Horiike A, Ohyanagi F, Yanagitani N, Nguyen L, Yaron Y, Borgman A, Tamura T
Clin Lung Cancer, S1525-7304(18), 30355-3, 2018年 - Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
Seki Y, Fujiwara Y, Kohno T, Yoshida K, Goto Y, Horinouchi H, Kanda S, Nokihara H, Yamamoto N, Kuwano K, Ohe Y
ESMO Open, 8(3(2)), e000292, 2018年 - Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trial
Horinouchi H, Kubota K, Miyanaga A, Nakamichi S, Seike M, Gemma A, Yamane Y, Kurimoto F, Sakai H, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Tamura T, Ohe Y
ESMO Open, 29(3(1)), e000288, 2018年 - Long-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisited
Sato J, Horinouchi H, Goto Y, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Ohe Y
J Thorac Dis, 10(3), 1696-1702, 2018年 - Evaluation of time to failure of strategy as an alternative surrogate endpoint in patients with lung cancer with EGFR mutations
Shinno Y, Goto Y, Watanabe S, Sato J, Morita R, Matsumoto Y, Murakami S, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Ohe Y
ESMO Open, 28(3), e000399, 2018年 - Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer
Sekine K, Kanda S, Kanda S, Goto Y, Horinouchi H, Fujiwara Y, Yamamoto N, Motoi N, Ohe Y
Lung Cancer, 124, 179-188, 2018年 - Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions
Ohara S, Kanda S, Okuma H, Goto Y, Horinouchi H, Fujiwara Y, Nokihara H, Ito Y, Yamamoto N, Usui K, Homma S, Ohe Y
Jpn J Clin Oncol, 48(1), 82-88, 2018年 - 【免疫療法の進歩と問題点】 免疫チェックポイント阻害薬と化学療法の併用
関根克敏, 神田慎太郎
腫瘍内科, 20(2), 100-105, 2018年
講演・口頭発表等
所属学協会
